Please login to the form below
More news articles
-
Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposteAlexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media
-
Eisai to tackle dementia in new US research facility Aims to introduce a new compound into the clinic by 2020
-
Sage surges after depression drug gets rapid path to approvalWill be able to file a marketing application based on its phase II trial
-
Weekly comms appointments Publicis Resolute, Road and W2O all add to their teams
-
UK, Germany back routine use of J&J’s TremfyaThe IL-23 inhibitor is currently being assessed in other EU countries
-
Health Unlimited bolsters PR teamAppoints Ann Bartling as PR practice lead
-
Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPOA rapid round up of today's pharma, biotech and healthcare news
-
GSK’s vaccines president Debruyne heads for the exitRoger Connor to take on the role in latest shake up
-
Jim Mellon's biotech Juvenescence raises $50m for anti-ageing therapiesBillionaire's belief in emerging anti-ageing therapies fuels start up
-
Daily Brief: PRIME status for vaccine, NHS urged to adopt automation, Brexit votes loomA rapid round up of pharma, biotech and healthcare news
-
Gates’ non-profit biotech for poverty diseases sets out its stall at BIOChief executive Heaton says GatesMRI will be a place where translational science meets medicine
-
Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestatAnother BACE candidate is abandoned, leaving just one remaining in the pipeline
-
Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHSA rapid round up of today's pharma, biotech and healthcare news
-
Cancer Research UK to test Asterias’ lung cancer vaccineThe vaccine could treat NSCLC patients who are at risk of relapse
-
Biogen appoints executive VP, corporate developmentDaniel Karp will also become a member of the executive committee
-
Exelixis appoints Andrew Peters to newly created positionHe joins the biotech as its vice president, strategy
Featured jobs
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Multi-Channel Account Managers - Road / Home-office based – Full...
-
Competitive salary
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Science Writer – Healthcare Advertising
-
Salary TBC
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie, Roche get FDA OK for broader use of Venclexta
- Moving annual total (MAT)
- UK pharma cheers EU science announcement
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS
- NICE set to reject Kyowa Kirin’s Crysvita for XLH
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- UK firm Nightstar bags FDA fast-track status for gene therapy
- British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
- Anthill Agency launch digital-focused academy
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Australian Flu and the dilemma of naming diseases
- ...
- Wearables and Healthcare
- What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
- What does a future-proof rep look like?
- Businesses can no longer afford to push ahead with the traditional Key Account Management model....
Quick links
Infographics
